Log inSign up
AAOIFI No. 21 screening

Is APRE halal?

Aprea Therapeutics, Inc.

Not halal

Aprea Therapeutics, Inc. did not pass AAOIFI screening. The failed check is shown below.

Checked: 14 October 2026

Exchange

NASDAQ

Price

0.5842

Day

-5.41%

Market cap

$7.6M

Industry

Biotechnology

Sector

Healthcare

What the company does

Aprea Therapeutics develops cancer drugs targeting DNA repair (ATR and WEE1 inhibitors), in early trials. No revenue.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $0 ÷ 36-month average market cap $14.97M = 0.0%

    0.0%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $41.23M ÷ 36-month average market cap $14.97M = 275.4%

    275.4%

    Fail

  • Non-compliant income / total revenue

    limit 5%

    —

    No data

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $7.63M.

In the lists

In the S&P 500
Not in the S&P 500

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyAPRE's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →
Is APRE halal? — Aprea Therapeutics, Inc. AAOIFI screening result — Limitup